Fundz

Radiant Biotherapeutics Emerges From Stealth Mode With $8 Million Seed Round And Two Pharma Partnerships

PRIVATEApr 25, 2023

Amount Raised

$8 Million

Round Type

Seed

TorontoBiotechnologyHealth CareTherapeutics

Description

Radiant Biotherapeutics, a revolutionary antibody platform company developing multi-valent, multi-specific therapeutics emerged from stealth mode unveiling an $8 million seed financing and two significant pharmaceutical partnerships. The Company, based on foundational IP from the labs of Dr. Jean-Philippe Julien at The Hospital for Sick Children (SickKids) and Dr. Bebhinn Treanor at the University of Toronto, was created by Amplitude Ventures which also led the seed round along with launch partner, SickKids and additional investors Alexandria Investments, FACIT and Toronto Innovation Acceleration Partners (TIAP).

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Radiant that raised within 45 days of this round, from Fundz verified event records.

  • Kate Therapeutics raised $51M (Series A) on June 8, 2023.
  • Acepodia raised $100M (Series D) on June 6, 2023.
  • Cyclo Therapeutics raised an undisclosed amount (Post-IPO Equity) on June 5, 2023.
  • Alkeus Pharmaceuticals raised $150M (Series B) on June 5, 2023.
  • Phio Pharmaceuticals raised $3M (Seed) on June 2, 2023.
  • Visgenx, Inc. raised $5.7M (Seed) on June 2, 2023.

Who to call at Radiant, and when

A new round usually means Radiant is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Radiant raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Radiant, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Radiant. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Radiant

Location

Toronto, Ontario, Canada

About

Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. The proprietary Multabody platform leverages avidity and multi-specificity simultaneously, to generate highly efficacious Multabodies with superior potency than other antibody platforms. These powerful Multabodies have potential to deliver a new class of biologics to tackle complex, heterogenous diseases, such as cancer, that often have challenging targets and mechanisms. Multabody production and manufacturing is flexible, modular and scalable, and leverages standard antibody CMC processes. The groundbreaking efficiency of the platform is driving a novel pipeline of mono-, bi- and tri-specific biologics in multiple therapeutics areas. Strategic partnerships with two leading biopharmaceutical companies validate the platform and its broad scientific and clinical utility.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Radiant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Radiant's next move

See what Strategic adds

Radiant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.